-
141
GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma
Published 2021-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
142
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
143
Targeting IL-33 in patients with cancer under immune checkpoint inhibitors for a better antitumor response and prevent thromboembolism?
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
144
Neoadjuvant anti-PD-1-based immunotherapy: evolving a new standard of care
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
145
Tumor CEMIP drives immune evasion of colorectal cancer via MHC-I internalization and degradation
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
146
TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
147
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinoma
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
148
Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
149
Correction: Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
150
Biology of extracellular vesicles and the potential of tumor-derived vesicles for subverting immunotherapy of cancer
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
151
Correction: Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
152
Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8+ T-cell antitumor activity via the non-canonical P53/STING pathway
Published 2025-02-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
153
Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
154
Treatment of pancreatic cancer with irreversible electroporation and intratumoral CD40 antibody stimulates systemic immune responses that inhibit liver metastasis in an orthotopic...
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
155
Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes
Published 2021-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
156
Transient lymphocyte count decrease correlates with oncolytic adenovirus efficacy in humans: mechanistic and biomarker findings from TUNIMO phase I trial
Published 2025-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
157
Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
158
Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
159
Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
160
Modulation of myeloid and T cells in vivo by Bruton’s tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma
Published 2023-01-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article